about
Systems immunology of human malariaVaccines for gonorrhea: can we rise to the challenge?Updates on the web-based VIOLIN vaccine database and analysis systemHIV-1 prophylactic vaccines: state of the artUtilizing population variation, vaccination, and systems biology to study human immunologySystems biology applied to vaccine and immunotherapy developmentSystems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic virusesOntology-supported research on vaccine efficacy, safety and integrative biological networksVaccines for the 21st centuryCD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive VaccinesImmune response to vaccine adjuvants during the first year of lifePrime-boost approaches to tuberculosis vaccine developmentReverse translation in tuberculosis: neutrophils provide clues for understanding development of active diseaseSystems vaccinology: probing humanity's diverse immune systems with vaccines.Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics ApproachA cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccinationAge-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infantsCancer immunotherapy via dendritic cellsSystems serology for evaluation of HIV vaccine trials.System vaccinology for the evaluation of influenza vaccine safety by multiplex gene detection of novel biomarkers in a preclinical study and batch release test.Innate immune sensing and response to influenza.Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate responseCell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled TrialImmunobiology of influenza vaccinesYellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.Vaccine adjuvant informatics: from data integration and analysis to rational vaccine adjuvant design.Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.Perspectives and Challenges of Microbial Application for Crop ImprovementSystems virology: host-directed approaches to viral pathogenesis and drug targeting.Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.The personal touch: strategies toward personalized vaccines and predicting immune responses to them.Systems-level analysis of innate immunity.Development of newborn and infant vaccinesHigh-resolution description of antibody heavy-chain repertoires in humans.Global analyses of human immune variation reveal baseline predictors of postvaccination responses.Metabolomics in the fight against malaria.A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacyRequirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines.Systems biology of natural simian immunodeficiency virus infections
P2860
Q21032488-4F2782C6-DBBF-4D8B-9442-9061B01ABA2EQ21131153-C3C6BE14-DBC5-48A9-98AF-64A98F7BF473Q24567754-776CF002-4F78-4A7E-A1A1-84F0ABE17250Q26740042-6F89CFA0-93AF-4C3D-A244-A47F9DEC03A5Q26799374-05EE2E45-509C-4C13-A464-60E7E8D4EEBEQ26830374-EBD14B53-3840-4D85-94A2-734B6FE6A2B0Q26866078-BA23E8B8-3107-4B7E-BAED-AFEA288EA341Q27005991-63F915D4-D3C7-4D8B-9ED4-AA1F24D8278FQ27007529-06169140-B52A-4B9F-9D91-D3B2475339AFQ27014949-F1979090-0308-4778-ABCB-EDDC6ECCB6C8Q27016633-008B83F4-E962-4BB0-877F-749CDC813A33Q27024526-A6534705-E55F-41CD-ABF0-88070EC417A0Q27027976-548C18CA-DA29-49E1-A091-96A032F0CBA1Q27690799-817CED92-A066-492C-BE99-B0BC65E1406DQ28074461-5E4D29BF-3E3E-4B4F-BA14-8B9B98DE39AEQ28543580-8B6F88A0-970E-437A-98B1-8A62B8A5FB12Q28741059-E7B1923C-2E3E-4DBA-9BF3-862088CA6AB1Q29615444-2C073891-3E2E-4363-851A-222976BD9737Q30238729-A95D6CB8-A5AC-48F0-9EB4-2F3433622847Q30364552-307898A3-C4C1-4825-86EE-D62FAECD0B6FQ30365302-207DE7DA-09B0-4ADC-A723-DCD73C151810Q30397031-0876ABC8-0C85-4390-956F-3FEFE41C4BF0Q30397652-089785FA-233F-43D7-90DD-1E4B53FD25B4Q30426771-09669494-5966-4F3A-9BEB-CE068586DBB1Q30490366-5F4371B8-CF06-4568-B5BF-F8C4FD8EB122Q30759814-2D9A7DEC-C42F-452A-87FE-0C99C812BC74Q30922949-99B1C942-B31D-4E13-B6A0-E8BD232D666FQ31165449-4DDBBC62-9002-4870-91F5-F88CC31F4A9EQ33637578-9188F18E-F212-4717-AA70-7500DD81FA5BQ33659753-BB456C69-2054-4919-96D1-1CDEBDDE583BQ33813977-315ECCE1-8B1B-41FB-BCB7-D2532F9A6497Q33855179-AA78C21B-B738-4EFE-B685-06C42C3418E5Q33941914-7625EEAC-1526-4851-A3BA-1D986D22EC66Q33988374-4DA93F4C-4E4A-4C5D-BB29-048F953B94A1Q34070648-42A6EBDD-64DC-41B1-B2B3-745E443B50F0Q34142744-1CB98B2B-82D5-4350-9E51-57F60B8E6CF4Q34166276-2E9FC404-ED63-4712-A409-7DF1D9C79639Q34225659-0642522C-EE11-4631-A58C-2B8DD1EDB8C1Q34390332-941B67F7-5033-4BAA-842B-EA903E7A250FQ34481980-C2B06F3E-51EC-41B3-86A1-89B16A3E36FA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Systems vaccinology.
@ast
Systems vaccinology.
@en
Systems vaccinology.
@nl
type
label
Systems vaccinology.
@ast
Systems vaccinology.
@en
Systems vaccinology.
@nl
prefLabel
Systems vaccinology.
@ast
Systems vaccinology.
@en
Systems vaccinology.
@nl
P2860
P1433
P1476
Systems vaccinology.
@en
P2093
Bali Pulendran
Shuzhao Li
P2860
P304
P356
10.1016/J.IMMUNI.2010.10.006
P407
P577
2010-10-01T00:00:00Z